Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

FDA greenlights its first therapy for advanced epithelioid sarcoma population

January 27, 2020
Sales and Marketing Cancer, Epizyme, FDA, Tazverik, pharma

The FDA has revealed the approval of its first therapy for the treatment of metastatic or locally advanced epithelioid sarcoma, …

News
janssen_latest_logo_on_sign_closer

European Commission expands Stelara for paediatric moderate to severe plaque psoriasis

January 24, 2020
Research and Development Europe, Janssen, Stelara, pharma

Janssen’s Stelara (ustekinumab) has seen its label expanded in Europe to include the treatment of moderate to severe plaque psoriasis …

News

Roche’s Tecentriq falls short as an adjuvant monotherapy in muscle-invasive urothelial cancer

January 24, 2020
Medical Communications, Sales and Marketing Cancer, Roche, pharma, tecentriq, trial failure

Roche has released an update on the development of its immunology Tecentriq (atezolizumab), making it known that the drug failed …

News
shutterstock_92671375

Former Insys sales exec sentenced to a year in prison for offering lap dances to encourage fentanyl spray prescriptions

January 23, 2020
Medical Communications, Sales and Marketing insys, pharma

A sales executive at the disgraced and bankrupted firm Insys who was accused of offering lap dances in order to …

News
shutterstock_95714119

Oxford Immunotec to supply TB diagnostic tests to china to aid in coronavirus crisis

January 23, 2020
Medical Communications, Sales and Marketing China, Oxford Immunotec Global, Wuhan, coronavirus, pharma

As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the …

News
roche__tree

Roche’s risdiplam hits main goal in infants with spinal muscular atrophy

January 23, 2020
Research and Development Roche, pharma, risdiplam, spinal muscular atrophy

Roche has announced the success of its survival motor neuron-2 (SMN2) splicing modifier risdiplam in a new trial investigating its …

News
fda2outsideweb

Horizon’s Tepezza becomes first and only FDA-approved drug for thyroid eye disorder

January 22, 2020
Research and Development FDA, Horizon Therapeutics, Tepezza, pharma

Horizon Therapeutics has announced that its IGF-1R inhibitor Tepezza (teprotumumab-trbw) has become the first and only therapy approved by the …

News

No NICE recommendation for AstraZeneca’s Tagrisso in EGFR+ lung cancer

January 22, 2020
Research and Development, Sales and Marketing AstraZeneca, NICE, Tagrisso, pharma

AstraZeneca’s Tagrisso (osimertinib) has been knocked back for routine use on the NHS in England and Wales by the drug …

News

Novartis establishes its new legal entity in Vietnam

January 22, 2020
Research and Development Novartis, Novartis Vietnam, oncology, pharma

Novartis has inaugurated its new legal entity in Vietnam, Novartis Vietnam Co Ltd, and has become one of the first …

News
roche__tree

EU approval for Roche’s Polivy combo in relapsed/refractory B-cell lymphoma

January 21, 2020
Manufacturing and Production, Sales and Marketing Cancer, Polivy, Roche, lymphoma, pharma

The European Commission has awarded conditional marketing approval to Roche’s Polivy (polatuzumab vedotin), it has been revealed.

News
jazz_pharma

Jazz Pharma’s Sunosi becomes first EU-approved drug of its kind in narcolepsy and sleep apnoea

January 21, 2020
Manufacturing and Production, Sales and Marketing jazz pharmaceuticals, narcolepsy, pharma

Jazz Pharmaceuticals has secured approval from the European Commission for Sunosi (solriamfetol), it has emerged, as a therapy to improve …

News
fda2outsideweb

Lynparza secures accelerated FDA review for metastatic castration-resistant prostate cancer

January 20, 2020
Sales and Marketing Cancer, FDA, lynparza, pharma

Following the recommendation of the tablet formulation of the drug for use on the NHS in England and Wales, news …

News
gettyimages-952692342-5c16809146e0fb0001dee456

Collaborating to realise the potential of precision medicine

January 20, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Precision Medicine, feature, pharma

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the …

Feature
steven_hildemann

Ipsen appoints new Exec VP and Chief Medical Officer

January 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs …

Appointment
landing-hero-images1

Japan welcomes approval of ViiV’s Dovato for HIV-1

January 17, 2020
Medical Communications, Sales and Marketing Dovato, Japan, ViiV Healthcare, pharma

Japan’s Ministry of Health, Labour and Welfare (MHLW) has awarded marketing approval to ViiV Healthcare, a subsidiary of GSK, for …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026